Search Result For: amy schumer mounjaro wegovy perimenopause

Date: 2025/06/07 - 09:00

Low-calorie diets may negatively impact mental health

People who restrict calorie intake to lose weight are more likely to have more depressive symptoms, recent research suggests.

Date: 2025/06/07 - 05:00

GLP-1 Drugs Linked to Age-Related Macular Degeneration, Study Finds

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with type 2 diabetes, according to a new study. The risk increased the longer people were prescribed a GLP-1 drug, particularly those containing semaglutide.

Date: 2025/06/06 - 01:32

‘Ozempic Teeth’ May Cause Tooth Decay, Other Dental Health Effects

People using GLP-1 drugs like Ozempic are reporting "Ozempic teeth," an unusual side effect impacting dental health. "Ozempic teeth" may involve tooth decay, sensitivity, and tooth loss. Dentists cite dry mouth, vomiting, and low appetite as possible causes.

two white pills on person's outstretched palm

Date: 2025/06/04 - 20:31

Could a sleeping pill help prevent toxic tau buildup in the brain?

Lemborexant, a medication commonly used to treat insomnia, may help protect the brain from tau buildup, a marker of Alzheimer's progression, a mouse study suggests.

A person holding a tray full of test tubes of blood to be sent off for Alzheimer's diagnosis

Date: 2025/05/22 - 21:00

First blood test for Alzheimer's gets FDA greenlight: 3 things to know

The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and beta-amyloid 1-42 in plasma.

A close up of the shoulder, neck and face of an older adult woman

Date: 2025/05/21 - 13:31

Alzheimer's affects biological aging, fat metabolism, and gut health, study shows

A new study reveals how Alzheimer’s disease affects different tissues across the entire body — including biological aging, fat metabolism, digestion, and reproduction.

Date: 2025/05/19 - 22:32

Zepbound More Effective for Weight Loss Than Wegovy, Eli Lilly Trial Shows

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk factors. Tirzepatide's dual effects on GLP-1 and GIP may explain its superior performance.

A person holding an Ozempic pen, the active ingredient of which is semaglutide

Date: 2025/05/18 - 16:31

Semaglutide may reduce heart disease risk, even within first 6 months

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular events after just six months of starting the medication, a new study indicates.

Two older adults walking on the beach barefoot as one puts an arm over the other and holds their shoes in the other hand

Date: 2025/05/16 - 14:31

Drug that slows Alzheimer's is safe and effective, real-world data shows

Significant adverse events — such as ARIA — with lecanemab, the drug that slows Alzheimer's, is rare and manageable, “real-world” data from people with mild Alzheimer's disease shows.

Date: 2025/05/15 - 23:32

FDA Accepts Novo Nordisk’s Application for Oral Wegovy: 5 Things to Know

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss medication Wegovy. Experts say an oral medication for weight loss might be more cost effective and easier for people to use.